Antiplatelet Drugs Resistance after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Chronic Kidney Disease

陈娜,季汉华
DOI: https://doi.org/10.13201/j.issn.1001-1439.2012.10.015
2012-01-01
Abstract:Objective To identify the incidence and related factors of aspirin and clopidogrel resistance in patients with acute coronary syndrome(ACS) undergoing percutaneous coronary intervention(PCI);To guide antiplatelet drugs use according to the results of thrombelastography(TEG) in patients with ACS. Methods Platelet inhibition situation in 67 patients with ACS undergoing PCI were detected by thrombelastography(TEG).Comparing the impact to aspirin and clopidogrel resistance among gender,age,smoking,family history,use of proton pump inhibitor(PPI),hypertension,hyperlipidemia,diabetes.Aspirin and clopidogrel resistance were predicted. Results In 67 ACS patients,there were 13 cases(19.4%) with low response to aspirin,9 cases(13.4%) with low clopidogrel response,3 cases(4.5%) with both low aspirin response and low clopidogrel response.There were 44.0%(11/25) with diabetes in patients with low platelet drug reactions,yet 11.9%(5/42) with diabetes in the patients with normal platelet drug reactions,there was significant difference between the two groups(P0.05).Proportion of women(60.0%) in patients with normal platelet drug reactions was significantly lower than that of low platelet drug reactions(19.1%),there was significant difference between the two groups(P0.05).The response of anti-platelet drugs would reduce with age(P0.05).And there were no significant difference among the proportions of smoking,family history,the use of proton pump inhibitor(PPI),combined hypertension,hyperlipidemia,etc(P0.05).Dichotomous variable linear regression analysis showed that the related factors of aspirin and clopidogrel resistance in patients with ACS included gender,age,diabetes. Conclusion Individualized antiplatelet therapy for ACS patients with diabetes mellitus of different gender and age can reduce the occurrence of clinical ischemic events.
What problem does this paper attempt to address?